Peter Sullivan is a Health Care Policy Reporter at Axios. He covers a range of topics within health care, including consumer health, pharmaceuticals, and public policy, often intertwining themes of wellness and politics. Peter's work has been featured in numerous outlets, including The Hill, WRBL News 3, and FOX 5 San Diego.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Peter Sullivan's coverage primarily focuses on national US government announcements, legal policy regulation, and healthcare-related themes. His articles often cover legislative actions related to healthcare policies, making him likely interested in pitches that provide insights into the impact of new legislation or regulatory changes on the healthcare industry.
Given his focus on government announcements and health policy, Peter may be receptive to expert commentary from individuals with direct experience in navigating legislative processes or implementing healthcare policies. Additionally, he might be interested in analysis from experts who can contextualize how specific regulations or bills could affect different stakeholders within the healthcare sector.
Since Peter's geographic focus is national (United States), relevant sources should have expertise in US healthcare legislation and a deep understanding of its potential implications at both federal and state levels.
This information evolves through artificial intelligence and human feedback. Improve this profile .
His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.
The CEO of the main pharmaceutical company trade group on Wednesday called for the next Food and Drug Administration commissioner to "calm the waters" and ensure stability as drug companies develop new treatments.
Offering hundreds of generic drugs on TrumpRx fills a key gap on the direct-to-consumer site.
By: Sanjay Rau, Garrick Gu, Matthew Petersile, Peter Sullivan, Sankirth Madabhushi
BackgroundEndoscopy-related injuries (ERIs) are common among endoscopists and can lead to decreased procedural volume, disability, and early retirement. The impact of physical conditioning on endoscopy-related musculoskeletal symptoms is not well studied. We aimed to investigate the association between exercise and the prevalence of self-reported endoscopy-related musculoskeletal symptoms (SERMS).MethodsWe conducted a cross-sectional survey of gastroenterology fellows and attendings at a tertiary-care academic center. Participants reported demographics, procedural volume, ergonomics training history, injury history, and exercise frequency and type. Exercise frequency was further categorized into fewer than four days/week or greater than or equal to four days/week of moderate-to-strenuous activity. Statistical analysis utilized Fisher’s exact and Mann-Whitney U tests.ResultsOf the 25 respondents (median age 37.5 years), 18 (72%) reported a history of SERMS. Endoscopists with fewer than or equal to six years of experience reported significantly higher rates of thumb pain (9 [69%] vs. 3 [25%], p = 0.047) and hand pain (6 [46%] vs. 0 [0%], p = 0.015) compared to established physicians. Physicians exercising at least four days per week had a significantly lower prevalence of thumb pain compared to those exercising less than four days (3 [23%] vs. 9 [75%]; p = 0.017). There were no significant associations between injury rates and procedural volume or prior ergonomics training.ConclusionERIs are highly prevalent, yet data regarding ergonomics and injury prevention are limited. In this study, frequent moderate-to-strenuous exercise was associated with decreased prevalence of self-reported thumb pain related to performing endoscopy. These findings support the need for further research on protective factors for SERMS and perhaps the institution of structured physical conditioning programs for endoscopist occupational health.
Added insurance costs are being passed through to workers who are already reeling from inflation.
The medical report didn't put to rest questions about bruising on Trump's hands, swollen ankles and his alertness.
Democratic states are pushing back on the Trump administration's rules for new Medicaid work requirements, warning that a chaotic rollout in the coming months could lead to even more people losing their coverage.
Why it matters: GOP lawmakers contend Medicare and Medicaid are rife with theft, but the new effort risks crossing the line into benefit cuts that could prompt political backlash in an election year.
Democrats argue Trump hasn't delivered meaningful results the way they did in 2022 through the Inflation Reduction Act.
A Senate plan to limit insulin costs in private insurance markets is getting new life after a key committee gave it bipartisan backing.
